CBD study for adults with autism and challenging symptoms
Treatments studied
Part of Mental health clinical trials.
This Phase 1 study tests cannabidiol (CBD) in adults on the autism spectrum who also have mood, sleep, or behavior problems. The goal is to learn whether CBD can be given safely and may help symptoms that affect daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of autism spectrum disorder based on DSM-5 criteria
- You currently have mood problems, sleep trouble, and/or agitation or aggression that affects daily life
- You do not have a past history of alcohol or substance use disorder
- Your urine drug test at the start must be negative for tetrahydrocannabinol (THC)
- You are not pregnant or breastfeeding, and you will not become pregnant during the study or within 3 months after
- Your liver health must be stable (no unstable liver disease)
- You are not taking certain medicines where CBD could change drug levels, such as clobazam
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests CBDV, a form of cannabis-based medicine, compared with placebo (dummy medicine) in children with autism who have significant irritability and social challenges. It aims to see whether CBDV can improve behavior and overall symptom severity safely over the study period.
This trial tests a cannabis oil enriched with terpenes (natural compounds that may affect behavior) to see if it helps reduce severe symptoms in children with autism. It compares the oil to a placebo.
This study tests a marijuana-based compound (similar to CBD but not psychoactive) to see if it helps reduce anxiety in autistic adults. You would take a daily capsule and be monitored for 12 weeks.
This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.
This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.
This study tests a treatment designed to help autistic adults with long-term sleep and circadian rhythm problems. It aims to improve sleep patterns and overall well-being.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.